These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38136371)

  • 1. Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling.
    Brynjulvsen M; Solli E; Walewska M; Zucknick M; Djirackor L; Langmoen IA; Mughal AA; Skaga E; Vik-Mo EO; Sandberg CJ
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
    Skaga E; Kulesskiy E; Fayzullin A; Sandberg CJ; Potdar S; Kyttälä A; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO
    BMC Cancer; 2019 Jun; 19(1):628. PubMed ID: 31238897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.
    Skaga E; Kulesskiy E; Brynjulvsen M; Sandberg CJ; Potdar S; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO
    Clin Transl Med; 2019 Dec; 8(1):33. PubMed ID: 31889236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target.
    Renoult O; Laurent-Blond M; Awada H; Oliver L; Joalland N; Croyal M; Paris F; Gratas C; Pecqueur C
    Neuro Oncol; 2024 Sep; 26(9):1572-1586. PubMed ID: 38869884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy.
    Tanaka S; Luk S; Kiyokawa J; Onozato ML; Iafrate AJ; Shah K; Martuza RL; Rabkin SD; Batchelor TT; Cahill DP; Chi AS; Wakimoto H
    Sci Rep; 2019 Jan; 9(1):139. PubMed ID: 30644426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome.
    Skaga E; Kulesskiy E; Potdar S; Panagopoulos I; Micci F; Langmoen IA; Sandberg CJ; Vik-Mo EO
    Transl Oncol; 2022 Dec; 26():101535. PubMed ID: 36115076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
    Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitivity of Patient-Derived Glioma Stem Cell 3-Dimensional Cultures to Photon, Proton, and Carbon Irradiation.
    Chiblak S; Tang Z; Campos B; Gal Z; Unterberg A; Debus J; Herold-Mende C; Abdollahi A
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):112-119. PubMed ID: 26254681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures.
    Maturi NP; Tan EJ; Xie Y; Sundström A; Bergström T; Jiang Y; Uhrbom L
    Glia; 2020 Jun; 68(6):1228-1240. PubMed ID: 31868967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.
    Bozzato E; Tsakiris N; Paquot A; Muccioli GG; Bastiancich C; Préat V
    Int J Pharm; 2022 Nov; 628():122341. PubMed ID: 36341916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.
    Haynes HR; Scott HL; Killick-Cole CL; Shaw G; Brend T; Hares KM; Redondo J; Kemp KC; Ballesteros LS; Herman A; Cordero-Llana O; Singleton WG; Mills F; Batstone T; Bulstrode H; Kauppinen RA; Wurdak H; Uney JB; Short SC; Wilkins A; Kurian KM
    J Pathol; 2019 Apr; 247(4):422-434. PubMed ID: 30565681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures.
    van den Hengel SK; Balvers RK; Dautzenberg IJ; van den Wollenberg DJ; Kloezeman JJ; Lamfers ML; Sillivis-Smit PA; Hoeben RC
    Cancer Gene Ther; 2013 Sep; 20(9):507-13. PubMed ID: 23907517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
    Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
    Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells.
    Rackov G; Iegiani G; Uribe D; Quezada C; Belda-Iniesta C; Escobedo-Lucea C; Silva A; Puig P; González-Rumayor V; Ayuso-Sacido Á
    Front Oncol; 2020; 10():1665. PubMed ID: 32974206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of U251 glioma stem cells and their heterogeneous stem-like phenotypes.
    Zhang S; Xie R; Wan F; Ye F; Guo D; Lei T
    Oncol Lett; 2013 Dec; 6(6):1649-1655. PubMed ID: 24260059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines Targeting Glioma Stem Cells.
    Sabu A; Liu TI; Ng SS; Doong RA; Huang YF; Chiu HC
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):158-181. PubMed ID: 35544684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLUG and Truncated TAL1 Reduce Glioblastoma Stem Cell Growth Downstream of Notch1 and Define Distinct Vascular Subpopulations in Glioblastoma Multiforme.
    Guelfi S; Orsetti B; Deleuze V; Rigau V; Bauchet L; Duffau H; Rothhut B; Hugnot JP
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.